Diabetes and Anaemia: A Myth or Reality
- PMID: 39346437
- PMCID: PMC11426576
- DOI: 10.4103/jpbs.jpbs_213_24
Diabetes and Anaemia: A Myth or Reality
Abstract
Introduction: Chronic diabetes develops when the pancreas does not release enough insulin or the body cannot use it. Anemia is a disorder characterized by reduced hemoglobin or red blood cells. The body needs hemoglobin to transport oxygen. Diabetics with anemia may have micro and macro vascular problems, lowering quality of life and increasing medical costs.
Aim and objectives: To examine the prevalence of anemia among type 2 diabetics, its predictive value, and the connection between anemia and type 2 diabetes.
Methodology: A prospective study was conducted on 2000 people with and without type 2 diabetes at the medical and diabetology wards of Punjab's Desh Bhagat University and hospital for medicine and health sciences from June 2022 to June 2023.
Results: A statistical significance threshold of 0.005 determined that the mean hemoglobin value was 8.44 in oral hypoglycemics, 7.93 in insulin, and 4.45 in combined insulin and oral hypoglycaemics.
Conclusion: Diabetics with type 2 diabetes mellitus and anemia were more likely to have CAD, making anemia a chronic condition that negatively impacts quality of life and accelerates disease consequences.
Keywords: Anemia; diabetes; hemoglobin; insulin.
Copyright: © 2024 Journal of Pharmacy and Bioallied Sciences.
Conflict of interest statement
There are no conflicts of interest.
Figures
Similar articles
-
The KID Study. III: Impact of inpatient rehabilitation on the metabolic control of type I and type II diabetics--a one-year follow-up.Exp Clin Endocrinol Diabetes. 1996;104(6):420-30. doi: 10.1055/s-0029-1211480. Exp Clin Endocrinol Diabetes. 1996. PMID: 9021342
-
Community-based care for the management of type 2 diabetes: an evidence-based analysis.Ont Health Technol Assess Ser. 2009;9(23):1-40. Epub 2009 Oct 1. Ont Health Technol Assess Ser. 2009. PMID: 23074528 Free PMC article.
-
Newly diagnosed anemia in admitted diabetics, frequency, etiology and associated factors.J Coll Physicians Surg Pak. 2015 Apr;25(4):242-6. J Coll Physicians Surg Pak. 2015. PMID: 25899186
-
Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.Pharmacoeconomics. 2004;22(6):389-411. doi: 10.2165/00019053-200422060-00005. Pharmacoeconomics. 2004. PMID: 15099124 Review.
-
Hydrogel-based Drug Delivery System in Diabetes Management.Pharm Nanotechnol. 2024;12(4):289-299. doi: 10.2174/0122117385266276230928064235. Pharm Nanotechnol. 2024. PMID: 37818559 Review.
Cited by
-
Anemia risk and mitigation strategies in type 2 diabetic patients: The role of novel antidiabetic agents.World J Diabetes. 2025 May 15;16(5):105549. doi: 10.4239/wjd.v16.i5.105549. World J Diabetes. 2025. PMID: 40487613 Free PMC article. Review.
References
-
- Ramachandran A, Snehalatha C. Current scenario of diabetes in India. J Diabetes. 2009;1:18–28. - PubMed
-
- Available from: https://anemiamuktbharat.info/
-
- Kaur H, Kochar R. A study on demographic and socioeconomic profile of diabetic patients. Int J Adv Res. 2017 doi: 10.21474/IJAR01/4482.
LinkOut - more resources
Full Text Sources
Miscellaneous